Bhattacharyya S, et al. (2004) Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood 104, 1100-9 15113757

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S473-p - Akt1 (mouse) ▲

Modsite: RPHFPQFsysAsGtA SwissProt Entrez-Gene Orthologous residues Akt1 (human): S473‑p, Akt1 iso2 (human): S411‑p, Akt1 (mouse): S473‑p, Akt1 (rat): S473‑p, Akt1 (fruit fly): S586‑p, Akt1 (cow): S473‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase wortmannin LPS inhibit treatment-induced increase LY294002 LPS inhibit treatment-induced increase

S9-p - GSK3B (mouse) ▲

Modsite: SGRPRttsFAEsCKP SwissProt Entrez-Gene Orthologous residues GSK3B (human): S9‑p, GSK3B iso2 (human): S9‑p, GSK3B (mouse): S9‑p, GSK3B (rat): S9‑p, GSK3B (rabbit): S9‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase

S32-p - IkB-alpha (mouse) ▲

Modsite: LVDDRHDsGLDsMKD SwissProt Entrez-Gene Orthologous residues IkB‑alpha (human): S32‑p, IkB‑alpha (mouse): S32‑p, IkB‑alpha (rat): S32‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase antibody increase IL-10 antibody inhibit treatment-induced increase

S36-p - IkB-alpha (mouse) ▲

Modsite: RHDsGLDsMKDEEYE SwissProt Entrez-Gene Orthologous residues IkB‑alpha (human): S36‑p, IkB‑alpha (mouse): S36‑p, IkB‑alpha (rat): S36‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase antibody increase IL-10 antibody inhibit treatment-induced increase

S180-p - IKKA (mouse) ▲

Modsite: DQGsLCTsFVGTLQY SwissProt Entrez-Gene Orthologous residues IKKA (human): S180‑p, IKKA (mouse): S180‑p, IKKA (rat): S180‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase antibody increase IL-10 antibody inhibit treatment-induced increase

S181-p - IKKB (mouse) ▲

Modsite: DQGsLCTsFVGTLQy SwissProt Entrez-Gene Orthologous residues IKKB (human): S181‑p, IKKB (mouse): S181‑p, IKKB (rat): S181‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase antibody increase IL-10 antibody inhibit treatment-induced increase

S534-p - NFkB-p65 (mouse) ▲

Modsite: sGDEDFssIADMDFS SwissProt Entrez-Gene Orthologous residues NFkB‑p65 (human): S536‑p, NFkB‑p65 (mouse): S534‑p, NFkB‑p65 (rat): S535‑p Characterization Methods used to characterize site in vivo:  phospho-antibody, western blotting Relevant cell lines - cell types - tissues:  bone marrow, spleen Cellular systems studied:  primary cells Species studied:  mouse Comments:  dendritic cells Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes LPS increase IL-10 LPS inhibit treatment-induced increase